Drugs News and Research

RSS

Aradigm’s common shares approved for listing on NASDAQ Capital Market

Aradigm Corporation is pleased to announce that its common shares have been approved for listing on the NASDAQ Capital Market.

9 Jun 2014

National Institutes of Health awards $3.4M grant for Alzheimer's disease research

As part of its ongoing research to better understand the complexities of the human brain, the Allen Institute for Brain Science is embarking on the first effort to map connectivity patterns across the whole brain in mouse models of Alzheimer's disease, through its recent award of a $3.4 million grant over five years from the National Institute on Aging of the National Institutes of Health.

9 Jun 2014

First Edition: June 9, 2014

Today's headlines include reports about efforts on the state level and within the health care system to address health care costs and advance other system reforms.

9 Jun 2014

Researchers identify critical weakness of invasive cancer cells

Metastatic cancer cells, which can migrate from primary tumors to seed new malignancies, have thus far been resistant to the current arsenal of anticancer drugs.

9 Jun 2014

Co-founder of Avidity Nanomedicines to receive 2014 Prince of Asturias Award

Avidity NanoMedicines LLC, a biopharmaceutical company pioneering a breakthrough approach to the targeted delivery of nucleic acid-based medicines, announced today that its scientific co-founder, Mark E. Davis, Ph.D., will receive the 2014 Prince of Asturias Award for Technical and Scientific Research.

9 Jun 2014

Kush Creams to manufacture and distribute medical marijuana product, 5 Hour High

Alternaturals, Inc., Symbol (OTCPink:ANAS) today announced that it has chosen Kush Creams, a Washington based, medical marijuana grower and distributor with award winning strains and products, to manufacture and distribute its long awaited medical marijuana product, 5 Hour High©.

9 Jun 2014

Advances in understanding of genetics of CAD lead to more therapeutic targets

Advances in the understanding of the genetics of coronary artery disease, or CAD, will revitalize the field and lead to more therapeutic targets for new medicines to combat this common disease, suggests a genetics expert from the Perelman School of Medicine at the University of Pennsylvania in a Perspective article in the new issue of Science Translational Medicine.

9 Jun 2014

Edison's EPI-743 receives FDA orphan drug designation for treatment of Leigh syndrome

Edison Pharmaceuticals today announced that the FDA has granted Orphan Drug status to vatiquinone for the treatment of Leigh syndrome.

9 Jun 2014

Viewpoints: Tea party missing the lesson; health care not an ordinary market; Va.'s Medicaid battle

But the Tea Party does have something to show for its five years of annoyance: Ted Cruz, senator from Texas. Cruz is probably best known for reading "Green Eggs and Ham" on the floor of the Senate during a 21-hour talkathon designed to ensure his place as the most hated man in that august chamber.

9 Jun 2014

Scientists unravel how herpesviruses fight against our immune system

How the virus does this was unknown until now. The scientists from the HZI research group "Viral Immune Modulation" under the leadership of Prof. Melanie Brinkmann have now been able to show that the virus is actively preventing activation of the innate immune system through Toll-like receptors.

9 Jun 2014

Reporters reflect on health law battles

Huffington Post gathers five reporters who followed the passage and implementation of the health law to share their insights.

9 Jun 2014

Research roundup: Funding for safety-net hospitals; insurance competition

Safety-net hospitals rely on disproportionate-share hospital (DSH) payments to help cover uncompensated care costs and underpayments by Medicaid

9 Jun 2014

Cellular blockages in nerve cells of insect's brain can form and dissolve in 30 seconds

Motorists in Los Angeles, San Francisco and other gridlocked cities could learn something from the fruit fly.

9 Jun 2014

Scientists develop new molecule for monitoring drug concentration

Monitoring the drug concentration in patients is critical for effective treatment, especially in cases of cancer, heart disease, epilepsy and immunosuppression after organ transplants.

9 Jun 2014

Gene variants that lead to longer telomeres boost brain cancer risk

New genomic research led by UC San Francisco scientists reveals that two common gene variants that lead to longer telomeres, the caps on chromosome ends thought by many scientists to confer health by protecting cells from aging, also significantly increase the risk of developing the deadly brain cancers known as gliomas.

9 Jun 2014

Scientists design nanoparticle to target tumor cells

Scientists at UC Santa Barbara have designed a nanoparticle that has a couple of unique - and important - properties.

9 Jun 2014

Researchers uncover several gene networks with potentially important roles in autism

A large new analysis of DNA from thousands of patients has uncovered several underlying gene networks with potentially important roles in autism.

9 Jun 2014

Tiny molecule may provide marker for depression

Levels of a small molecule found only in humans and in other primates are lower in the brains of depressed individuals, according to researchers at McGill University and the Douglas Institute.

9 Jun 2014

Progress in constructing protein nanomachines

A route for constructing protein nanomachines engineered for specific applications may be closer to reality.

6 Jun 2014

New targets could increase effectiveness and reduce side effects linked with breast cancer treatments

Scientists from the Florida campus of The Scripps Research Institute (TSRI) have found new targets for potential intervention in breast cancer. These new targets could eventually increase effectiveness and reduce the undesirable side effects associated with current treatments.

6 Jun 2014